Additionally, Andexanet alfa also inhibits the anticoagulant effect of heparin by reversibly binding to the heparin-antithrombin III complex in vitro, resulting in heparin resistance [5, 6] and leading to possible antithrombin III deficiency. This evidence concerns the gene SERPINC1 and hyperinsulinemic hypoglycemia, familial, 4.